Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis

The purpose of this Phase 1, first in uveitis open-label study is to assess the safety and tolerability of TRX-103 in patients with non infectious uveitis (NIU). It is anticipated that up to 18 Subjects will be enrolled during a 18-24 month enrollment period. TRX-103 will be infused one time.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Quan Dong NguyenUpdated: Feb 23, 2026Locations: 1
Eligibility criteria

≥ 18 to ≤ 70 years of age at time of consent. [+8]

Any condition preventing evaluation/assessment of both eyes. [+58]

Status: Recruiting

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety, tolerability, and distribution of Laquinimod administered as topical eye drops for two weeks in human participants.

Participants needed: 12
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Quan Dong NguyenUpdated: May 14, 2025Locations: 1
Eligibility criteria

Age 18 years or older [+4]

Participants with active periocular or ocular infectious disease (e.g., blephari... [+16]